TITLE

Osler-Weber-Rendu syndrome

AUTHOR(S)
Morphet, John A. M.
PUB. DATE
November 2006
SOURCE
CMAJ: Canadian Medical Association Journal;11/7/2006, Vol. 175 Issue 10, p1243
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor John A.M. Morphet is presented regarding Osler-Weber-Rendu syndrome concerning treatment of telangiectasia.
ACCESSION #
22907817

 

Related Articles

  • Bevacizumab and type 1 idiopathic macular telangiectasia. Koay, C L; Chew, F L M; Visvaraja, S // Eye;Dec2011, Vol. 25 Issue 12, p1663 

    A letter to the editor is presented which discusses a case report of type 1 idiopathic macular telangiectasia (IMT) in a 76-year-old man who successfully treated with intravitreal bevazinumab.

  • Response to 'Bevacizumab and type 1 idiopathic macular telangiectasia'. Ooto, S; Takayama, K; Yoshimura, N // Eye;Dec2011, Vol. 25 Issue 12, p1665 

    A response by S. Ooto and colleagues to a letter to the editor about their article "Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia" in the 2010 issue is presented.

  • Chance diagnosis. Schnur, Walter // Cortlandt Forum;5/25/95, Vol. 8 Issue 5, p40 

    Relates the author's experience of improperly diagnosing but curing an elderly patient with telangiectasia. Response to oral iron, vitamin B12 and folic acid; Gastroduodenoscopy; Treatment by laser light fulguration.

  • New tools, techniques improve telangiectasia treatment. Guttman, Cheryl // Dermatology Times;Sep95, Vol. 16 Issue 9, p20 

    Reports on advances in the treatment of leg telangiectasia. Use of sodium tetradecyl sulfate; Recognition of the importance of treating reticular veins; Application of post-treatment compression.

  • Get rid of telangiectases by first treating reticular veins. Sabbagh, Leslie // Dermatology Times;May97, Vol. 18 Issue 5, p20 

    Explores on the best approach for eliminating telangiectatic veins as reported by Dr. Michael P. Goldman. How to determine the exact location of the telangiectases; Contraindication of ambulatory phlebectomy. INSET: Another approach to telangiectasia treatment..

  • Erase fine red lines. Boyer, Pamela // Prevention;Nov95, Vol. 47 Issue 11, p126 

    Reports on the treatment of telangiectasia or spider veins on the face. Treatment of facial veins with electric current, lasers and a intense-pulsed light system.

  • Anesthesia for laser Tx of facial telangiectasias.  // Cosmetic Surgery Times;Jan/Feb2002, Vol. 5 Issue 1, p11 

    Examines the applicability of botulinum toxin-A (Botox) injected as anesthesia for laser treatment of facial telangiectasias. Recommendations from Doctor Joseph Niamtu from American Academy of Cosmetic Surgeons; Guidelines for its application in the surgical process; Advantages on its application.

  • New device safely cools skin during laser ablation. Zabel, Karen // Dermatology Times;Jul96, Vol. 17 Issue 7, p80 

    Features the cooling device that simultaneously cools the skin during laser ablation which also offers a promising alternative to sclerotherapy in the treatment of lower extremity telangiectasia greater than 0.2 millimeter in diameter. Cool Laser Optics (CLO) as the name given to the device;...

  • Pulsed dye laser effective Tx for facial telangiectasia. Sabbagh, Leslie // Dermatology Times;Jul2001, Vol. 22 Issue 7, p25 

    Reports that facial telangiectasias can be effectively treated with the pulsed dye laser with extended pulse durations. Description of how the pulsed dye laser treats facial telangiectasias; Impact of the configuration of the pulse train; Potential side effects of the laser treatment.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics